Beverly Hills Private Wealth LLC boosted its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% in the second quarter, Holdings Channel reports. The institutional investor owned 4,101 shares of the company’s stock after buying an additional 80 shares during the period. Beverly Hills Private Wealth LLC’s holdings in Procter & Gamble were worth $637,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of Procter & Gamble by 99,734.1% during the second quarter. Bank Julius Baer & Co. Ltd Zurich now owns 253,081,478 shares of the company’s stock valued at $38,402,583,000 after acquiring an additional 252,827,976 shares during the last quarter. Moneta Group Investment Advisors LLC lifted its holdings in Procter & Gamble by 96,526.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock worth $5,840,449,000 after buying an additional 38,495,676 shares during the period. Norges Bank bought a new stake in shares of Procter & Gamble in the 4th quarter valued at about $3,752,321,000. Price T Rowe Associates Inc. MD increased its stake in shares of Procter & Gamble by 42.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 24,386,838 shares of the company’s stock valued at $3,626,080,000 after buying an additional 7,235,990 shares during the period. Finally, Morgan Stanley raised its position in shares of Procter & Gamble by 12.6% during the fourth quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock worth $6,717,246,000 after acquiring an additional 4,959,527 shares during the last quarter. 63.43% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $151.42 on Thursday. The company has a current ratio of 0.67, a quick ratio of 0.48 and a debt-to-equity ratio of 0.51. The stock has a market cap of $356.88 billion, a PE ratio of 24.58, a price-to-earnings-growth ratio of 3.16 and a beta of 0.47. The stock’s fifty day simple moving average is $149.33 and its two-hundred day simple moving average is $150.76. The Procter & Gamble Company has a 1-year low of $135.83 and a 1-year high of $158.38.
Procter & Gamble Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Stockholders of record on Friday, October 20th were paid a dividend of $0.9407 per share. The ex-dividend date was Thursday, October 19th. This represents a $3.76 annualized dividend and a dividend yield of 2.49%. Procter & Gamble’s payout ratio is 61.04%.
Insider Buying and Selling
In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 188 shares of the stock in a transaction dated Friday, October 20th. The shares were sold at an average price of $148.52, for a total transaction of $27,921.76. Following the completion of the transaction, the chief accounting officer now owns 626 shares in the company, valued at $92,973.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, CAO Matthew W. Janzaruk sold 188 shares of the stock in a transaction on Friday, October 20th. The stock was sold at an average price of $148.52, for a total transaction of $27,921.76. Following the sale, the chief accounting officer now owns 626 shares in the company, valued at $92,973.52. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO R. Alexandra Keith sold 781 shares of Procter & Gamble stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $152.82, for a total value of $119,352.42. Following the completion of the transaction, the chief executive officer now owns 6,310 shares of the company’s stock, valued at $964,294.20. The disclosure for this sale can be found here. In the last 90 days, insiders sold 76,427 shares of company stock valued at $11,548,535. 0.17% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the stock. DZ Bank raised shares of Procter & Gamble from a “sell” rating to a “hold” rating and set a $155.00 target price for the company in a research report on Friday, October 20th. Stifel Nicolaus lowered their target price on shares of Procter & Gamble from $161.00 to $151.00 and set a “hold” rating for the company in a research note on Monday, October 16th. HSBC initiated coverage on shares of Procter & Gamble in a research report on Friday, September 22nd. They set a “buy” rating and a $179.00 price target on the stock. JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $172.00 to $169.00 and set an “overweight” rating on the stock in a research note on Thursday, October 12th. Finally, StockNews.com raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Monday, November 6th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $165.83.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
- Five stocks we like better than Procter & Gamble
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Buffett’s latest portfolio additions, trims, and cuts in Q3
- What Are MATANA Stocks?
- 5 reasons TJX Companies will hit new highs in 2024
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Game-changing news for Ambarella puts the market in reversal
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.